United States Deep Vein Thrombosis Interventions Landscape Report 2022: Focus on Interventional Radiologists and Vascular Surgeons
October 13, 2022 04:28 ET
|
Research and Markets
Dublin, Oct. 13, 2022 (GLOBE NEWSWIRE) -- The "The United States Deep Vein Thrombosis Interventions Landscape, Procedure and Technology Trends, Brand Perception, Competitive Intelligence and Future...
Anthos Therapeutics Launches Second Phase 3 Clinical Trial of Its Dual-acting Factor XI Inhibitor, Abelacimab
August 25, 2022 08:00 ET
|
Anthos Therapeutics
Abelacimab is the only Factor XI inhibitor currently being evaluated in Phase 3 trials The MAGNOLIA study will compare abelacimab against the current standard of care for VTE in cancer associated...
Worldwide Varicose Vein Treatments Industry to 2026 - Impact of Demographic, Economic, and Other Factors That Will Drive Future Demand
May 14, 2021 05:03 ET
|
Research and Markets
Dublin, May 14, 2021 (GLOBE NEWSWIRE) -- The "Global Varicose Vein Treatments Market 2021-2026" report has been added to ResearchAndMarkets.com's offering. Varicose veins treatment includes...
Amaranth Medical Completes MEND-II and RENASCENT Studies and Initiates Study of 120-Micron APTITUDE Sirolimus-Eluting Bioresorbable Scaffold
October 15, 2015 08:00 ET
|
Amaranth Medical, Inc.
MOUNTAIN VIEW, CA, Oct. 15, 2015 (GLOBE NEWSWIRE) -- Amaranth Medical, a privately held medical device company, announced that enrollment has successfully concluded in its multi-center, international...
Amaranth Medical Reports Positive Safety and Feasibility Findings for the FORTITUDE(TM) Bioresorbable Scaffold
October 28, 2013 08:00 ET
|
Amaranth Medical, Inc.
MOUNTAIN VIEW, CA, Oct. 28, 2013 (GLOBE NEWSWIRE) -- Amaranth Medical, a privately held medical device company,
presented positive six-month angiographic results from its
first-in-human study...
Dr. Alan Daugherty Named Editor of ATVB Journal
July 02, 2012 13:01 ET
|
American Heart Association
DALLAS, July 2, 2012 (GLOBE NEWSWIRE) -- The American Heart Association and Lippincott Williams & Wilkins, a part of Wolters Kluwer Health, are pleased to announce the appointment of Alan...